New drug for chronic hives that don't respond to allergy pills
Part of Immune system & allergy, Skin clinical trials.
This study tests an investigational medication called lesigercept for people with chronic hives that don't get better with standard allergy pills. The goal is to see if it can reduce itching and hives better than placebo.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had hives (itchy welts) almost daily for at least 6 months.
- You are still getting hives and itching despite taking a daily allergy pill (like Zyrtec or Claritin).
- You have been taking the same dose of your allergy pill every day for at least the past week.
- You are between 18 and 75 years old.
- You do not have another skin condition (like eczema) that could affect the hives assessment.
- You do not have a serious medical condition (like heart disease, untreated infections, or cancer in the last 5 years).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new oral medication (TLL-018) for people with chronic hives that don't fully go away with standard antihistamines. It aims to see if the drug reduces itching and hives better than placebo.
This trial tests a new oral medication for chronic spontaneous urticaria (chronic hives). It is a placebo-controlled study, meaning some participants will get the new drug and some will get a placebo (a pill with no active ingredient). The goal is to see if the new drug is safe and how well it works, possibly providing a new treatment option for those whose hives are not controlled by current antihistamines.
This trial tests a new daily pill called TLL-018 (a JAK inhibitor) for people with chronic hives that still cause symptoms despite taking antihistamines. It aims to see how fast it relieves itching and hives.
This study tests an investigational pill called THB335 for adults whose hives (itchy welts) keep appearing despite taking antihistamines. The goal is to see if this treatment can reduce itching and hives and improve quality of life.
This trial tests a new injection (CM512) for people with chronic spontaneous urticaria, also known as chronic hives. If you have had itchy hives for at least 6 weeks despite taking regular antihistamines, this study may help find a new treatment option.
This trial tests an experimental drug called ICP-332 for people with chronic spontaneous urticaria (long-term hives) that is not well controlled by standard antihistamines. The goal is to see if the drug is safe and effective at reducing hives.
Hear when a new Allergic Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.